Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Inflammatory Bowel Disease IV: Pharmacological Management01:29

Inflammatory Bowel Disease IV: Pharmacological Management

1.0K
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
1.0K
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

529
Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
529
Nephrotic Syndrome III : Nursing Management01:24

Nephrotic Syndrome III : Nursing Management

533
Nursing management for nephrotic syndrome adapts as the disease progresses, with strategies evolving to address advancing symptoms and complications.Early-Stage Management In the early stages, nursing interventions for nephrotic syndrome resemble those used in managing acute glomerulonephritis, focusing on symptom monitoring, fluid balance, and managing mild to moderate edema.Vital Signs: Regularly monitor blood pressure, pulse, respiratory rate, and temperature to promptly identify...
533
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

604
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
604
Asthma-IV: Nursing Management01:30

Asthma-IV: Nursing Management

4.0K
The nursing management of asthma is a comprehensive approach that relies heavily on the expertise and dedication of healthcare professionals. It involves thorough assessment, accurate diagnosis, strategic planning, effective implementation, and diligent evaluation. By meticulously following this step-by-step process, healthcare professionals play a crucial role in providing the best possible care and treatment for patients with asthma, enhancing their overall health and well-being.
First, in...
4.0K
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents01:29

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

734
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
734

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Diagnosing rheumatoid arthritis: challenges and opportunities.

Best practice & research. Clinical rheumatology·2022
Same author

Rheumatoid arthritis: Evolving recognition of a common disease.

Best practice & research. Clinical rheumatology·2022
Same author

Antinuclear Antibodies and Lupus: Label Versus Meaning.

Arthritis care & research·2019
Same author

ACR Presidential Address: Building on the Strengths of Our Unique Specialty.

Arthritis & rheumatology (Hoboken, N.J.)·2019
Same author

How Should We Consider Lupus Without Antinuclear Antibodies?

Arthritis care & research·2018
Same author

Common Language Description of the Term Rheumatic and Musculoskeletal Diseases (RMDs) for Use in Communication With the Lay Public, Healthcare Providers, and Other Stakeholders Endorsed by the European League Against Rheumatism (EULAR) and the American College of Rheumatology (ACR).

Arthritis & rheumatology (Hoboken, N.J.)·2018

Related Experiment Video

Updated: Apr 21, 2026

Author Spotlight: Evaluating Traditional Chinese Therapy for Ankylosing Spondylitis in Mice
04:47

Author Spotlight: Evaluating Traditional Chinese Therapy for Ankylosing Spondylitis in Mice

Published on: October 27, 2023

2.2K

Advances in managing ankylosing spondylitis.

David I Daikh1, Patty P Chen2

  • 1Division of Rheumatology, University of California San Francisco, 400 Parnassus Avenue, San Francisco, CA 94143 USA ; San Francisco VA Medical Center 4150 Clement Street, San Francisco, CA 94121 USA.

F1000Prime Reports
|October 25, 2014
PubMed
Summary

Ankylosing spondylitis (AS) management has advanced with new therapies, including anti-tumor necrosis factor agents, improving patient outcomes and potentially preventing spinal damage. Early diagnosis using MRI for non-radiographic disease is also key.

More Related Videos

Preliminary Study on Acupuncture Combined with Grain-sized Moxibustion for Treating Rheumatoid Arthritis with Finger Joint Pain
04:50

Preliminary Study on Acupuncture Combined with Grain-sized Moxibustion for Treating Rheumatoid Arthritis with Finger Joint Pain

Published on: May 16, 2025

1.5K
An Adoptive Transfer Model of Rheumatoid Arthritis in Mice
07:37

An Adoptive Transfer Model of Rheumatoid Arthritis in Mice

Published on: June 6, 2025

1.4K

Related Experiment Videos

Last Updated: Apr 21, 2026

Author Spotlight: Evaluating Traditional Chinese Therapy for Ankylosing Spondylitis in Mice
04:47

Author Spotlight: Evaluating Traditional Chinese Therapy for Ankylosing Spondylitis in Mice

Published on: October 27, 2023

2.2K
Preliminary Study on Acupuncture Combined with Grain-sized Moxibustion for Treating Rheumatoid Arthritis with Finger Joint Pain
04:50

Preliminary Study on Acupuncture Combined with Grain-sized Moxibustion for Treating Rheumatoid Arthritis with Finger Joint Pain

Published on: May 16, 2025

1.5K
An Adoptive Transfer Model of Rheumatoid Arthritis in Mice
07:37

An Adoptive Transfer Model of Rheumatoid Arthritis in Mice

Published on: June 6, 2025

1.4K

Area of Science:

  • Rheumatology
  • Immunology
  • Radiology

Background:

  • Ankylosing spondylitis (AS) is a chronic inflammatory condition affecting the spine and sacroiliac joints.
  • It often causes significant spinal deformity and disability.
  • Current treatments offer improved symptoms and function for many patients.

Purpose of the Study:

  • To review recent advances in the understanding and management of ankylosing spondylitis.
  • To highlight the role of new therapeutic agents and diagnostic imaging.
  • To discuss the implications for preventing disease progression.

Main Methods:

  • Review of current clinical research and therapeutic developments in AS.
  • Emphasis on anti-tumor necrosis factor agents and emerging therapies.
  • Discussion of diagnostic advancements, particularly MRI for non-radiographic disease.

Main Results:

  • Effective therapies, including anti-TNF agents, improve symptoms and function.
  • Therapy may prevent further structural damage in the spine.
  • MRI identifies active inflammation in non-radiographic spondylitis, which responds to treatment.

Conclusions:

  • Significant progress has been made in managing ankylosing spondylitis.
  • Early diagnosis and targeted therapies are crucial for better outcomes.
  • New agents and diagnostic tools offer promise for this debilitating condition.